The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism
Joint Authors
Asutay, Fatih
Atalay, Yusuf
Asutay, Hilal
Acar, Ahmet H.
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-07-05
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Objectives.
Nocturnal bruxism can be managed by botulinum toxin (Botox®) in patients who have not responded to conservative treatment.
The aim of this study was to evaluate the efficacy of botulinum toxin A (BTXA) in the treatment of nocturnal bruxism.
Material and Methods.
The retrospective study comprised 25 female patients, aged 23–55 years (mean 35.84±8.41 years).
All patients received a single injection of BTXA in the right and left masseters.
Evaluation was made by Visual Analogue Scale (VAS) values, complaint duration, onset of effect, and duration of effectiveness.
Results.
BTXA produced significant improvements in pain scores.
Only 2 adverse events (8%) were recorded.
Conclusion.
BTX-A is effective in the treatment of nocturnal bruxism.
American Psychological Association (APA)
Asutay, Fatih& Atalay, Yusuf& Asutay, Hilal& Acar, Ahmet H.. 2017. The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism. Pain Research and Management،Vol. 2017, no. 2017, pp.1-5.
https://search.emarefa.net/detail/BIM-1197442
Modern Language Association (MLA)
Asutay, Fatih…[et al.]. The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism. Pain Research and Management No. 2017 (2017), pp.1-5.
https://search.emarefa.net/detail/BIM-1197442
American Medical Association (AMA)
Asutay, Fatih& Atalay, Yusuf& Asutay, Hilal& Acar, Ahmet H.. The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism. Pain Research and Management. 2017. Vol. 2017, no. 2017, pp.1-5.
https://search.emarefa.net/detail/BIM-1197442
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1197442